James Llontop is latest Contender Series winner to get released by the UFC. Llontop was coming off a loss on short notice before his release.

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

Cenntenial Park, on Hovey Road off Wallace Drive. Jan. 4-5 and Jan. 11-12, 9:30 a.m. to 3:30 p.m. The rest of the time the ...

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...

Fusion is the same energy that powers the sun and other stars. Nuclear power, which currently provides almost 20% of the country’s electricity generation and will play a big role in America’s ...

GI-102 is under clinical development by GI Innovation and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR) ...

Let’s dig in. SARATOGA SPRINGS — The Phila Street space that formerly housed Phila Fusion is up for lease. It’s listed with Christopher Armer, a licensed real estate association broker with ...

Gourmet food trucks in India are revolutionizing street food by offering imaginative fusion dishes, global flavors, and ...

AKS-452 is under clinical development by Vakston and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Tectonic Therapeutic, Inc. has seen a significant stock rally which has seen its shares nearly triple since this summer. What ...

Atlanta United FC has hired Chris Henderson to be its next ... Henderson also went on to play for the Kansas City Wizards, the Miami Fusion, the Columbus Crew and the New York Red Bulls.

JSKN033-102 is an open-label, multicenter, Phase Ⅰ/Ⅱ clinical study designed to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics and anti-tumor activity of JSKN033 in patients with ...